red violet Announces Pricing of $100 Million Underwritten Public Offering of Common Stock

Rhea-AI Summary

red violet (NASDAQ: RDVT) priced a previously announced underwritten public offering of 1,666,667 common shares at $60.00 per share, for expected gross proceeds of $100 million before fees and expenses. The offering is expected to close on August 7, 2026, subject to customary conditions.

red violet granted underwriters a 30-day option to buy up to an additional 250,000 shares at the same public price, less underwriting discounts and commissions. According to red violet, net proceeds will be used for working capital and general corporate purposes, including potential strategic acquisitions. Raymond James and Needham & Company are joint book-running managers, with B. Riley Securities and Craig-Hallum as co-managers, under an effective shelf registration filed with the SEC.

Positive

• $100 million gross proceeds expected from common stock offering
• Use of proceeds includes working capital and potential strategic acquisitions
• Underwriters granted 30-day option for up to 250,000 additional shares

Negative

• Offering of 1,666,667 new shares implies equity dilution for existing shareholders
• Underwriters’ option for 250,000 extra shares could increase dilution further

News Explained

The offering is priced but not yet closed: if it closes as expected on August 7, 2026, issuing 1,666,667 new shares would leave existing holders with smaller percentage ownership, while red violet receives the $100 million gross proceeds before fees.

Market Context

The platform records an active S-3 shelf with $150,000,000 capacity and 2 usages; that financing con...

Analysis

The platform records an active S-3 shelf with $150,000,000 capacity and 2 usages; that financing context frames the offering beyond its stated proceeds. Net Selling insider sentiment adds a monitoring risk, while remaining capacity is not provided.

Key Figures

Shares offered: 1,666,667 shares Offering price: $60.00 per share Gross proceeds: $100 million +5 more

8 metrics

Shares offered 1,666,667 shares Underwritten public offering

Offering price $60.00 per share Public offering

Gross proceeds $100 million Before underwriting discounts, commissions, and offering expenses

Expected closing August 7, 2026 Subject to customary closing conditions

Underwriter option 30-day option Additional common-stock purchase option

Additional shares 250,000 shares Maximum shares under underwriter option

Shelf filing date November 19, 2025 Form S-3 filed with the SEC

Shelf effective date November 25, 2025 Shelf registration declared effective by the SEC

Historical Context

5 past events · Latest: Jul 28 (Neutral)

5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 28	earnings scheduling	Neutral	+5.5%	Announcement scheduled second-quarter 2026 results for August 10 after market close
Jul 20	market expansion	Positive	+2.0%	FOREWARN launched home-healthcare safety intelligence beyond its established real-estate user base
Jul 06	technology partnership	Positive	+4.9%	IDI listed identity-graph datasets on Snowflake Marketplace for Cortex AI analytics
May 29	service expansion	Positive	+3.7%	FOREWARN added identity-verification services for 10,000-plus Hawaii REALTORS members statewide
May 28	investor conference	Neutral	+4.9%	Company announced June 11 presentation at East Coast IDEAS Investor Conference

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

underwritten public offering, shelf registration statement, form s-3, prospectus supplement

4 terms

underwritten public offering financial

"announced the pricing of its previously announced underwritten public offering"

An underwritten public offering is when a company sells new shares of its stock to the public with the help of a financial firm, called an underwriter. The underwriter agrees to buy all the shares upfront, reducing the company's risk, and then sells them to investors. This process helps companies raise money quickly and confidently from a wide range of buyers.

shelf registration statement regulatory

"A shelf registration statement on Form S-3 relating to the shares"

A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.

form s-3 regulatory

"A shelf registration statement on Form S-3 relating to the shares"

Form S-3 is a legal document companies use to register their stock sales with the government, making it easier and faster for them to raise money by selling shares to investors. It’s like having a pre-approved shopping list that lets a company quickly sell new shares when they need funds, without going through a lengthy approval process each time.

prospectus supplement regulatory

"made only by means of a prospectus supplement and accompanying prospectus"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOCA RATON, Fla., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Red Violet, Inc. (“red violet”) (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 1,666,667 shares of its common stock at a public offering price of $60.00 per share. The gross proceeds to red violet from the Offering, before deducting underwriting discounts and commissions and offering expenses payable by red violet, are expected to be $100 million. The Offering is expected to close on August 7, 2026, subject to customary closing conditions. In addition, red violet has granted the underwriters a 30-day option to purchase up to an additional 250,000 shares of common stock at the public offering price, less the underwriting discounts and commissions.

red violet intends to use the net proceeds from the Offering for working capital and general corporate purposes, including potential strategic acquisitions.

Raymond James and Needham & Company are acting as joint book-running managers and representatives of the underwriters for the Offering. B. Riley Securities and Craig-Hallum are acting as co-managers.

A shelf registration statement on Form S-3 relating to the shares of common stock offered in the Offering was previously filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 19, 2025, and declared effective by the SEC on November 25, 2025. The Offering is being made only by means of a prospectus supplement and accompanying prospectus. A preliminary prospectus supplement relating to and describing the terms of the Offering has been filed with the SEC and may be obtained for free by visiting the SEC’s website at www.sec.gov. A final prospectus supplement containing additional information relating to the Offering and an accompanying prospectus will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. Once available, copies of the final prospectus supplement and the accompanying prospectus may be obtained from: Raymond James & Associates, Inc., Attention: Equity Syndicate, 880 Carillon Parkway, St. Petersburg, Florida 33716, by telephone at (800) 248-8863, or by email at prospectus@raymondjames.com; or Needham & Company, LLC, 250 Park Avenue, 10th Floor, New York, NY 10177, by telephone at (800) 903-3268, or by email at prospectus@needhamco.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, and shall not constitute an offer, solicitation, or sale in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of that state or jurisdiction. Any offers, solicitations of offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

About red violet®

At red violet, we build proprietary technologies and apply analytical capabilities to deliver identity intelligence. Our technology powers critical solutions, which empower organizations to operate with confidence. Our solutions enable the real-time identification and location of people, businesses, assets, and their interrelationships. These solutions are used for purposes including identity verification, risk mitigation, due diligence, fraud detection and prevention, regulatory compliance, and customer acquisition. Our intelligent platform, CORE™, is purpose-built for the enterprise, yet flexible enough for organizations of all sizes, bringing clarity to massive datasets by transforming data into intelligence. Our solutions are used today to enable frictionless commerce, to ensure safety, and to reduce fraud and the concomitant expense borne by society.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking statements,” as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipate,” “believes,” “should,” “intends,” “estimates,” and other words of similar meaning. These forward-looking statements include statements regarding the Offering, including the expected timing and completion thereof, the anticipated gross proceeds from the Offering and red violet’s intended use of net proceeds from the Offering. These forward-looking statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties, and assumptions. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release, and are advised to consider the factors listed above together with the additional factors under the headings “Forward-Looking Statements” and “Risk Factors” in red violet’s Form 10-K for the year ended December 31, 2025, filed on March 4, 2026, as may be supplemented or amended by red violet's other filings with the SEC. red violet undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

Company Contact:

Camilo Ramirez
Red Violet, Inc.
561-757-4500
ir@redviolet.com

Investor Relations Contact:

Steven Hooser
Three Part Advisors
214-872-2710
ir@redviolet.com

FAQ

What are the key terms of red violet (NASDAQ: RDVT) August 2026 stock offering?

red violet priced an underwritten public offering of 1,666,667 shares at $60.00 per share, targeting $100 million gross proceeds. According to red violet, closing is expected on August 7, 2026, subject to customary closing conditions.

How much capital will red violet (RDVT) raise from its 2026 underwritten offering?

red violet expects to raise $100 million in gross proceeds from the offering, before underwriting discounts, commissions, and expenses. According to red violet, net proceeds will fund working capital and general corporate purposes, including potential strategic acquisitions.

What is the share price and size of the red violet (RDVT) public offering?

The public offering is priced at $60.00 per share for 1,666,667 shares of common stock. According to red violet, this structure implies expected gross proceeds of $100 million, excluding any additional shares from the underwriters’ option.

Does the red violet (RDVT) 2026 stock offering include an underwriters’ option?

Yes. red violet granted underwriters a 30-day option to purchase up to 250,000 additional shares at the public price, less discounts. According to red violet, this option is in addition to the base 1,666,667 shares offered.

How will red violet use the proceeds from its August 2026 RDVT offering?

red violet plans to use net proceeds for working capital and general corporate purposes, including potential strategic acquisitions. According to red violet, the capital will support ongoing operations and may fund future strategic transaction opportunities as they arise.

When is the expected closing date of the red violet (RDVT) common stock offering?

The offering is expected to close on August 7, 2026, subject to customary conditions. According to red violet, completion depends on satisfaction of standard closing requirements typical for underwritten public equity offerings in U.S. capital markets.

Which investment banks are managing the red violet (RDVT) $100 million stock offering?

Raymond James and Needham & Company are joint book-running managers and underwriter representatives. According to red violet, B. Riley Securities and Craig-Hallum are serving as co-managers for this underwritten public offering under an effective SEC shelf registration.